Translate

Saturday, April 7, 2018

International Money Laundering Can Be The Basis for Large Bounty Actions and Other Whistleblower Reward Lawsuits That Can Pay Out Hundreds of Millions or Even Billions of Dollars by International Money Laundering Whistleblower Reward

International Money Laundering Can Be The Basis for Large Bounty Actions and Other Whistleblower Reward Lawsuits That Can Pay Out Hundreds of Millions or Even Billions of Dollars by International Money Laundering Whistleblower Reward Lawyer Jason Coomer

International Money Laundering can be the basis of large whistleblower reward lawsuits including SEC bounty actions that pay large financial rewards to financial professionals who confidentially and properly expose large scale money laundering schemes and other financial fraud schemes.  To learn more about confidentially exposing large money laundering schemes or other illegal financial schemes, please go to the following web pages: Money Laundering Whistleblower Reward Lawyer, Whistleblower Reward Laws, Federal False Claims Act Information, and International Whistleblower Reward Information Center.

Large Scale International Money Laundering and Other Financial Crimes Can Be the Basis of Large Whistleblower Reward Lawsuits Paying Vast Amounts to Professionals Who Properly Expose Illegal Financial Schemes

It is estimated that over $1 Trillion is laundered globally each year.  This large about of money being laundered can create large financial rewards for those that properly report specific types of money laundering under whistleblower reward laws and bounty action laws because many of these laws base the financial rewards on the amount of money laundering identified and recovered.   Financial professionals, investors, and other high end whistleblowers that have original knowledge or evidence of money laundering scheme are encouraged to confidentially report through a lawyer.  By confidentially and properly reporting these money laundering schemes, the financial professional, investor, or other high end whistleblower can earn large financial rewards.  An example of these rewards would be between $500 million to $1.5 billion, if a Bounty Action resulted in a fine and recovery of $5 Billion. 

Sunday, July 31, 2016

The Globalization of International Trade and Standardization of Anti-bribery and Corruption Laws Have Led to the Enactment of International Whistleblower Laws That Reward International Professionals for Anonymously Exposing Fraud

The Globalization of International Trade and Standardization of Anti-bribery and Corruption Laws Have Led to the Enactment of International Whistleblower Laws That Reward International Professionals for Anonymously Exposing Foreign Corrupt Practices Act Violations Including Illegal Bribes, Supply Chain Fraud, and Accounting Fraud

Through globalization of international trade, there has been a shift in many international manufacturing supply chains. As such, raw material supplies for pharmaceuticals, medical supplies, medical equipment, electronics, and several other regulated products that have traditionally come from the United States and Europe are now coming from China and India. This manufacturing shift has created an environment where adulterated ingredients to pharmaceuticals, medical supplies, and medical devices as well as counterfeit parts for weapons and electronics may be used in the manufacturing of products and can create dangerous and adulterated drugs, medical supplies, and medical devices as well as dangerous and defective weapons, computers, aircraft, and vehicles.

For this reason international professionals are being offered large financial rewards to properly expose supply chain fraud including bribes, accounting fraud, and dangerous regulated products.  Under SEC FCPA whistleblower reward laws, an international professional can report these Foreign Corrupt Practice Act violations anonymously through a lawyer to protect their identity and career from potential retaliation.

The Globalization of the Pharmaceutical Industry

Every year over $4.1 trillion (US dollars) is spent worldwide on health services including approximately $850 billion (US dollars) that is spent in the pharmaceutical market on drugs and medications.  In 2011, it is estimated that global pharmaceutical sales are expected to grow by 5% to 7% to around $880 billion.  This growth in sales is led by the 17 so-called "pharmerging countries," which include China, Brazil, Russia, India, Venezuela, Poland and the Ukraine.  These "pharmerging countries", are forecast to see their pharmaceutical spending grow at a 15% to 17% rate in 2011, to between $170 billion and $180 billion overall.

For more information on Globalization in the Pharmaceutical Industry, please go to the following web pages: Globalization in the Pharmaceutical Industry, Drug Company Bribe Whistleblowers, and Doctors in China Are Needed to Expose Illegal Drug Bribes and Fraudulent Marketing Schemes.

The Globalization of Electronics, Weapons Systems, and Aircraft

Globalization of supply chains in international trade has created a shift in where many component parts are produced.  This shift includes the production of electronic components that are used in aircraft, military weapons systems, computers, medical equipment, and other products that are purchased by the United States government through procurement contracts.  These electronic components were traditionally manufactured in the United States and Europe, but are now being manufactured in China, Mexico, India, and South America.  When these electronic components are fake or substandard parts, false certifications regarding the quality of these electronic components can be the subject of a Qui Tam False Claims Act Whistleblower Reward Lawsuit. These lawsuits encourage whistleblowers including international whistleblowers along the electronic component supply chain to blow the whistle on fake military electronic components, low quality electronic components, and other counterfeit electronic parts.

For more information on Globalization in the Electronics, Weapons Systems, and Aircraft, please go to the following web page: Globalization of Electronics, Weapons Systems, and Aircraft.

Thursday, June 16, 2016

China Drug Company Bribe Scheme Whistleblowers Can Earn Large Financial Rewards By Confidentially Reporting Illegal Bribes Through a Lawyer To The SEC by China Drug Company Bribe Whistleblower Reward Lawyer

China Drug Company Bribe Scheme Whistleblowers Can Earn Large Financial Rewards By Confidentially Reporting Illegal Bribes Through a Lawyer To The SEC by China Drug Company Bribe Whistleblower Reward Lawyer Jason S. Coomer

Under the Foreign Corrupt Practices Act and the SEC Whistleblower Incentive Program, whistleblowers with original and specialized knowledge and evidence of corporate bribery and illegal kickbacks are eligible to recover large economic awards.  By gathering this evidence and going through a lawyer, these whistleblowers can protect their identity through the process and potentially collect large rewards of 10% to 30% of the monetary sanctions including disgorged funds.  In cases where systematic bribery schemes have created large drug company revenues of over $1 billion USD, these rewards can be between $100 million USD and $300 million USD.  For more information on this topic, please go to the following web pages:  Chinese Doctors Are Needed to Expose Drug Bribery Schemes and Expose Drug Company Bribes and Earn Large Rewards.

The Chinese Drug Market Is The Target of Many Multinational Drug Companies  

The Chinese pharmaceutical market is one of the fastest growing drug markets in the world.  To capitalize on this fast growing market several drug companies are offering illegal bribes and other incentives to Chinese doctors in order to increase drug sales in China.  These illegal bribery schemes include paying Chinese doctors and Chinese health officials with gift cards, illegal trips, and slush funds to prescribe specific drugs and influence treatment guidelines.

Some of these bribery schemes are extremely complicated and involve systematic gifts given to doctors through accounting fraud and marketing fraud.  Such marketing schemes are illegal under Chinese law and can be the basis for large SEC Bounty Action Rewards.

China Drug Company Bribe Whistleblower Lawyer Jason Coomer Helping Whistleblowers Report Fraud and Claim Rewards

Jason Coomer, who heads a law firm in Austin, Texas, has a Chinese language website offering assistance to whistleblowers. His office and his co-counsel have received around 50 whistleblower reports from China in the last three years and are now taking eight cases forward to the SEC.

We're talking large multinational corporations with multi-billion dollar contracts each year. The whistleblowers are insiders at the corporations as well as doctors who have witnessed elaborate bribery schemes, he told Reuters in on telephone interview from Texas. He declined to give further details about the cases.
   

Wednesday, June 15, 2016

Chinese Doctors Can Confidentially Expose Drug Company Bribes and Earn Large Financial Rewards

Chinese Doctors Can Confidentially Expose Drug Company Bribes and Earn Large Financial Rewards by China Drug Whistleblower Lawyer Jason Coomer

Doctors and other medical professionals are being offered large financial rewards and whistleblower protections to expose drug company bribes, medical device company bribes, and medical supply company bribes.  These whistleblower protections include being able to file a bounty action through an international whistleblower lawyer in order to protect the medical professional's identity.  For more information on exposing illegal bribes and collecting large rewards, please go to the following web page: Chinese Doctors Can Confidentially Expose Drug Company Bribes.

Drug Company Bribes, Medical Device Company Bribes, and Medical Supply Company Bribes in China Can
Be The Basis For Large Bounty Action Rewards

Every year over $4.1 trillion (US dollars) is spent worldwide on health services including approximately $850 billion (US dollars) that is spent in the pharmaceutical market on drugs and medications. In 2011, it is estimated that global pharmaceutical sales are expected to grow by 5% to
7% to around $880 billion. This growth in sales is led by the 17 so-called "pharmerging countries," which include China, Brazil, Russia, India, Venezuela, Poland, and Ukraine. These "pharmerging countries", are forecast to see their pharmaceutical spending grow at a 15% to 17% rate in 2011, to between $170 billion and $180 billion overall.

It is estimated that approximately 10 to 25% of public health care procurement spending including drug contracts, medicine purchases, and pharmaceutical contracts are lost to corrupt and fraudulent acts. As such, there is an international movement to reward pharmaceutical professionals and health care professionals that expose fraudulent and corrupt practices that cost hundreds of billions of dollars and cost lives. This international movement includes SEC Foreign Corrupt Practices Act Whistleblower Reward Lawsuits and traditional Qui Tam False Claims Act Whistleblower Reward Lawsuits which offer whistleblowers large rewards for properly exposing bribes.  Medical providers with first hand knowledge or evidence of large bribes are encouraged to step forward to properly expose these illegal bribes.

Wednesday, July 15, 2015

Government Contract Bribes Can Be the Basis of International Whistleblower Reward Lawsuits That Pay Large Financial Rewards To Whistleblowers by Government Contract Bribe Whistleblower Reward Lawyer

International Government Contract Bribes Can Be the Basis of International Whistleblower Reward Lawsuits That Pay Large Financial Rewards To Whistleblowers by Government Contract Bribe Whistleblower Reward Lawyer Jason S. Coomer

Government contracts are estimated to be over $10 Trillion each year.  It is estimated that as much as 20% of these government contracts are through illegal bribes, kickbacks, and other illicit payments.  Government contracts include spending on military; public works projects; public health care (pharmaceuticals, medical equipment, & hospitals); ports, transportation, & roads; mining and oil extraction; power grid and stations; education; law enforcement; and sanitation services. 

If you have evidence of a government contract illegal bribery scheme, illegal kickback scheme, or other illicit payment scheme, it can be extremely financially beneficial to expose the corruption through a government contract bribe whistleblower reward lawyer.  The lawyer can protect your identity while reviewing your potential case as well as in some instances obtain a large reward from the SEC.  For more information regarding a government contract whistleblower reward lawsuit, please go to the following web page: Foreign Corrupt Practices Act Goverment Contract Whistleblower Reward Lawsuits.

Saturday, April 12, 2014

International Bribery Lawyer Confidentially Reviews FCPA Bounty Actions for Whistleblowers by International Bribery Lawyer Jason S. Coomer

International Bribery Lawyer Confidentially Reviews Foreign Corrupt Practices Act Bribery Scheme Bounty Actions for International Whistleblowers by International Bribery Lawyer and International Bribery Scheme Bounty Action Lawyer Jason S. Coomer

Under the Foreign Corrupt Practices Act and the new SEC Whistleblower Incentive Program, whistleblowers with original and specialized knowledge and evidence of corporate bribery and illegal kickbacks are eligible to recover large economic awards.  By gathering this evidence and properly reporting international bribery scheme to the SEC through an international bribery lawyer, these whistleblowers can protect their identity through the process and potentially collect large rewards of 10% to 30% of the monetary sanctions obtained through the SEC enforcement action.  These rewards can include disgorged funds or the benefit of the bribery damages which can be in the Billions of dollars. 

If you are aware of an illegal bribe or illegal kickback that was used to secure a large contract, please feel free to submit a confidential inquiry or go to the follow web page for more information: International Bribery Lawyer.

Sunday, February 9, 2014

Expose Russia Olympic Bribes: Olympic Bribes and Construction Bribes Can Be The Basis of Large Whistleblower Rewards

Expose Russia Olympic Bribes: Olympic Bribes and Construction Bribes Can Be The Basis of Large Whistleblower Rewards by International Whistleblower Lawyer Jason S. Coomer

Russian whistleblowers, public officials, business professionals, employees of multinational corporations, and others that have evidence of Russian government corruption are eligible for large whistleblower financial rewards.  Russian government corruption that can be the basis for these
awards include illegal payments for business; bribes for construction contracts; illegal incentives for oil, gas and mineral leases; illegal kickbacks for regulatory approval; and other violations of Foreign
Corrupt Practices Act (FCPA).  Russian whistleblowers and multinational corporation whistleblowers are needed to step up to report illegal corrupt practices and can receive large financial rewards for being the first to properly expose significant Russian government corruption.

If you are aware of a significant Foreign Corrupt Practice Act (FCPA) violation, please feel free to go to the following webpage: Russian Whistleblower Rewards or contact Russian Government Whistleblower  Lawyer, Jason Coomer via e-mail message

Contractor flees Russia after refusing to pay Olympic bribes - CBS News

"A new report by a Russian anti-corruption group says the total cost for the games has soared to about $50 billion -- more than five times as much as the last winter games.  Yet the best place to discover why costs have risen so high may not be among the gleaming new venues, but on a street in a town just outside London, where Valery Morozov, once an Olympic contractor -- now a fugitive -- lives."

"Miscalculated, he said, because the local Olympic organizers told him to add about $30 million
to his bill for various Sochi construction projects, and then pay that money back to them as kickbacks."

"The only one reason for this was their pockets," Morozov said. "There was only one reason." Morozov rebuilt some of the crumbling facilities of the old Sochi resort. The kickbacks, he said, followed a familiar formula. The kickback was about 40 percent of the total contract." 

Saturday, February 8, 2014

Expose Illegal Medical Device, Medical Equipment, and Pharmaceutical Bribes: International Whistleblower Reward Lawyer Jason S. Coomer

The SEC Is Offering Large Rewards To International Whistleblowers That Can Properly Expose Medical Device Bribes, Medical Equipment Bribes, and Pharmaceutical Bribes to Physicians by International Whistleblower Lawyer Jason S. Coomer

International whistleblowers can recover large amounts of money for exposing international pharmaceutical and medical device bribes.  By exposing procurement kickbacks, medicine supply chain bribes, and other violations of the Foreign Corrupt Practices Act, a physician or other whistleblower can not only help expose corruption, but can receive a large reward.  As such, pharmaceutical representatives, international drug executives, government officials, physicians, health care providers, community activists, and other persons, who are the original source of
specialized knowledge of international drug company bribes, international pharmaceutical company illegal kickback schemes, medical device and equipment procurement bribery schemes, and other illicit payments for drug procurement, medical device procurement, and medical equipment contracts.

For more information on a potential Foreign Corrupt Practices Act Whistleblower Reward Lawsuit, please go to the following web page: Medical Device, Medical Equipment, and Pharmaceutical Bribe Lawsuits or please feel free to send an e-mail message to International Whistleblower Reward Lawyer Jason Coomer

SEC.gov | SEC Charges Stryker Corporation With FCPA Violations

An SEC investigation found that Stryker Corporation’s subsidiaries in Argentina, Greece, Mexico, Poland, and Romania made illicit payments totaling approximately $2.2 million that were incorrectly described as legitimate expenses in the company’s books and records.  Descriptions varied from a charitable donation to consulting and service contracts, travel expenses, and commissions.  Stryker made approximately $7.5 million in illicit profits as a result of the improper payments.

Stryker has agreed to pay more than $13.2 million to settle the SEC’s charges.

Johnson & Johnson

The SEC alleges that, since at least 1998, J&J’s subsidiaries paid bribes to public doctors in Greece who selected J&J surgical implants, paid bribes to public doctors and hospital administrators in
Poland who awarded tenders to J&J, and paid bribes to public doctors in Romania to prescribe J&J pharmaceutical products. J&J also paid kickbacks to Iraq in order to obtain contracts under the United Nations Oil for Food Program (“Program”).

J&J has agreed to pay more than $48.6 million in disgorgement and prejudgment interest to settle the SEC’s charges and to pay a $21.4 million fine to the U.S. Department of Justice to settle criminal
charges. A resolution of a related investigation by the United Kingdom Serious Fraud Office is anticipated.

The SEC’s complaint alleges that J&J subsidiaries, employees, and agents paid bribes to public doctors and administrators in Greece, Poland, and Romania. Doctors who ordered or prescribed J&J products were rewarded in a variety of ways, including cash and inappropriate travel. A variety of schemes were used to carry-out the bribery, including the use of slush funds, sham civil contracts with doctors, and off-shore companies in the Isle of Man. A J&J executive was involved in the Greek conduct, and MD&D Poland executives running three business lines oversaw the creation of sham contracts, travel documents, and the creation of slush funds in Poland. The SEC’s complaint also alleges that J&J’s agent paid secret kickbacks to Iraq to obtain nineteen Oil for Food contracts.

Tuesday, December 3, 2013

Public Health Care Bribes To Government Officials: Glaxo CEO on U.K. China Trade Mission Amid Bribery Probe - Bloomberg

Public Health Care Bribes To Government Officials Can Be The Basis For Large Whistleblower Rewards by International Public Health Care Bribe Lawyer Jason S. Coomer

International whistleblowers can recover large amounts of money for exposing international medicine procurement kickbacks, medicine supply chain bribes, and other violations of the Foreign Corrupt Practices Act.  As such, pharmaceutical representatives, international drug executives, government officials, physicians, health care providers, community activists, and other persons, who are the original source of specialized knowledge of international drug company bribes, international pharmaceutical company illegal kickback schemes, public health medicine procurement bribery schemes, and other illicit payments for drug procurement, medical device procurement, medication, pharmaceutical, and medical equipment contracts.

For more information on this topic and confidential reviews of Public Health Care Bribe Whistleblower Reward Lawsuits, please go to the following web page:  International Medicine Bribe Whistleblower Reward Law Center.

Each Year Approximately $1 Trillion In Public Health Care Contracts Are Obtained Through Bribes and Illegal Kickbacks

Every year over $4.1 trillion (US dollars) is spent worldwide on health services including approximately $750 billion (US dollars) that is spent in the pharmaceutical market on drugs and medications. It is estimated that approximately 10 to 25% of public health care procurement spending including drug contracts, medicines, pharmaceuticals, medical equipment, and medical devices is lost to corrupt and fraudulent acts.  These acts include government official bribes, illegal kickbacks, and other illicit payment and fraud schemes.

Glaxo CEO on U.K. China Trade Mission Amid Bribery Probe - Bloomberg

Glaxo agreed last year to pay a record $3 billion fine in the U.S. to settle allegations that the company illegally marketed medicines. That settlement came with a “Corporate Integrity Agreement” with the U.S. government that requires Glaxo to report any investigation or legal proceedings.

“Ongoing risks include the global regulatory fallout, foremost in the U.S., from any repercussions in China,” Kepler Cheuvreux’s environmental, social and governance research team said in a report on corruption in the pharmaceutical industry last month.

Anti-corruption investigations may also spill over to other countries such as India, Brazil and Russia, especially during election years, according to Kepler analyst Sudip Hazra.
“They could potentially use these precedents in the U.S. and China to embolden them politically,” Hazra said.


Saturday, November 30, 2013

International Public Health Bribes and Whistleblower Rewards: SEC Charges Pfizer with FCPA Violations | Investor.gov


International Whistleblower Reward Laws Offer Financial Rewards and Bounties to International Whistleblowers That Expose Illegal Bribes to Government Officials by Confidential International Illegal Bribe Whistleblower Lawyer Jason S. Coomer

International whistleblowers can recover large rewards for exposing international medicine procurement kickbacks, public health care bribes, and other violations of the Foreign Corrupt Practices Act.  As such, pharmaceutical representatives, international drug executives, government officials, physicians, health care providers, community activists, and other persons, who are the original source of specialized knowledge of international bribes and illegal kickbacks are encouraged to contact an international whistleblower lawyer to have their whistleblower reward case confidentially reviewed.

For more information on a potential Foreign Corrupt Practices Act Whistleblower Reward Lawsuit, please go to the following web page on International Public Health Care Bribe Whistleblower Reward Lawsuits or use our submission form.

SEC Charges Pfizer with FCPA Violations | Investor.gov

The SEC alleges that employees and agents of Pfizer’s subsidiaries in Bulgaria, China, Croatia, Czech Republic, Italy, Kazakhstan, Russia, and Serbia made improper payments to foreign officials to obtain regulatory and formulary approvals, sales, and increased prescriptions for the company’s pharmaceutical products. They tried to conceal the bribery by improperly recording the transactions in accounting records as legitimate expenses for promotional activities, marketing, training, travel and entertainment, clinical trials, freight, conferences, and advertising.

The SEC separately charged another pharmaceutical company that Pfizer acquired a few years ago – Wyeth LLC – with its own FCPA violations. Pfizer and Wyeth agreed to separate settlements in which they will pay more than $45 million combined to settle their respective charges. In a parallel action, the Department of Justice announced that Pfizer H.C.P. Corporation agreed to pay a $15 million penalty to resolve its investigation of FCPA violations.

“Pfizer subsidiaries in several countries had bribery so entwined in their sales culture that they offered points and bonus programs to improperly reward foreign officials who proved to be their best customers,” said Kara Brockmeyer, Chief of the SEC Enforcement Division’s Foreign Corrupt Practices Act Unit. “These charges illustrate the pitfalls that exist for companies that fail to appropriately monitor potential risks in their global operations.”

According to the SEC’s complaint against Pfizer filed in U.S. District Court for the District of Columbia, the misconduct dates back as far as 2001. Employees of Pfizer’s subsidiaries authorized and made cash payments and provided other incentives to bribe government doctors to utilize Pfizer products. In China, for example, Pfizer employees invited “high-prescribing doctors” in the Chinese government to club-like meetings that included extensive recreational and entertainment activities to reward doctors’ past product sales or prescriptions. Pfizer China also created various “point programs” under which government doctors could accumulate points based on the number of Pfizer prescriptions they wrote. The points were redeemed for various gifts ranging from medical books to cell phones, tea sets, and reading glasses. In Croatia, Pfizer employees created a “bonus program” for Croatian doctors who were employed in senior positions in Croatian government health care institutions. Once a doctor agreed to use Pfizer products, a percentage of the value purchased by a doctor’s institution would be funneled back to the doctor in the form of cash, international travel, or free products.

Sunday, June 16, 2013

Foreign Corrupt Practices Act SEC Bounty Actions, Whistleblower Rewards, and Confidential Reviews by International Foreign Corrupt Practices Act Bounty Action Lawyer Jason S. Coomer

Foreign Corrupt Practices Act SEC Fraud Whistleblower Bounty Actions Are Designed to Expose Significant SEC and FCPA Violations by Offering Large Financial Rewards to People That Are The Original Source of Information That Expose Illegal Bribes, Kickbacks, and other SEC FCPA Violations by International FCPA Lawyer

SEC Fraud Whistleblower Lawsuits or SEC Bounty Actions are a product of the enactment of the Dodd-Frank Wall Street Reform and Consumer Protection Act.  These laws were designed to create bounties that can be collected by whistleblowers that properly report Foreign Corrupt Practices violations, illegal brides, kickback schemes, money laundering, SEC violations, international financial fraud, securities fraud, and commodities fraud that result in monetary sanctions over one million dollars ($1,000,000.00).  The SEC can award the whistleblower up to 30% of the money collected.

By creating whistleblower bounties for investors and people with specific information of fraud, it is expected that hard to detect fraud will be exposed to help regulate the financial market and prevent large investment corporations, banks, hedge funds, and other large corporations from committing financial fraud of billions of dollars.  Further, new whistleblower protection laws allow potential whistleblowers to confidentially report potential bounty actions through a lawyer.  These protections allow professionals to protect their identities and career while having a potential bounty action reviewed.


 International Illegal Bribery Schemes Can Be The Basis of SEC Bounty Actions

The Foreign Corrupt Practices Act (FCPA) prohibits bribery of foreign officials by U.S. and foreign companies listed on the U.S. securities exchange.  The FCPA also requires such companies to maintain accurate books and records.  Foreign Corrupt Practices Act Whistleblowers that properly report violations of the FCPA by a U.S. or foreign company listed on the U.S. securities exchanges can recover a large reward for exposing FCPA violations.


If you are aware of a significant Foreign Corrupt Practice Act  violation, please feel free to contact Foreign Corrupt Practices Act Whistleblower Reward Lawyer Jason Coomer via e-mail message or go to the following web site: International Illegal Bribery Schemes and International Whistleblower Reward Information

Monday, April 29, 2013

Foreign Corrupt Practices Act Whistleblower Rewards by Confidential Foreign Corrupt Practices Act Whistleblower Lawyer Jason S. Coomer

Foreign Corrupt Practices Act Whistleblowers Can Received Large Financial Rewards For Exposing International Bribes, Illegal Kickbacks, Slush Funds, and other Illegal Activities by International Foreign Corrupt Practices Lawyer Jason S. Coomer

The Foreign Corrupt Practices Act and the new SEC Whistleblower Incentive Program work together to reward whistleblowers with original and specialized knowledge and evidence of international business corporate bribery and illegal kickbacks.  These new international business whistleblower reward laws are part of a worldwide movement to expose and punish government corruption such as contract bribes, illegal kickbacks, and large scale international fraud.  These Foreign Corrupt Practices Act should help prevent government corruption in many countries including Russia, China, Mexico, and Brazil.

For more information on this topic, please go to the following web page:  International Business Bribery Whistleblower Reward Lawyer.

Sunday, April 28, 2013

Parker Drilling Company (Release No. LR-22672; April 16, 2013)

Parker Drilling Company (Release No. LR-22672; April 16, 2013)

SEC Charges Parker Drilling Company with Violating the Foreign Corrupt Practices Act

The Securities and Exchange Commission today charged Parker Drilling Company, a worldwide drilling services and project management firm, with violating the Foreign Corrupt Practices Act (FCPA) by authorizing improper payments to a third-party intermediary retained to assist the company in resolving customs disputes.

The SEC's complaint, filed in federal district court in Alexandria, Virginia, alleges that in 2004 Parker Drilling authorized payments to a Nigerian agent totaling $1.25 million. The company did so despite former senior executives knowing that the agent intended to use the funds to "entertain" Nigerian officials involved in resolving Parker Drilling's ongoing customs problems. Following the Nigerian agent's work, the company received an unexplained $3,050,000 reduction of a previously assessed customs fine, and the company was permitted to nationalize and sell its Nigerian rigs.

To settle the SEC's charges, Parker Drilling will pay disgorgement of $3,050,000 plus pre-judgment interest of $1,040,818. Parker Drilling consented to the entry of a final judgment permanently enjoining it from violating Sections 30A, 13(b)(2)(A), and 13(b)(2)(B) of the Exchange Act. The proposed settlement is subject to court approval.

In the parallel criminal proceedings, the Department of Justice entered into a Deferred Prosecution Agreement with Parker Drilling in which the company will pay an $11,760,000 penalty.

International Oil Company Employee Whistleblowers Can Earn Large Rewards for Exposing Fraud and Violations of SEC Laws

Under the Dodd-Frank Wall Street Reform and Consumer Protection Act, all domestic and foreign companies registered with the U.S. Securities and Exchange Commission (SEC) must publicly report how much they pay governments for access to their oil, gas and minerals, beginning in FY2012. These payments must be reported on a country-by-country and a project-by-project basis, and will likely cover a wide range of the material benefits that accrue to governments from extractive deals.  This Dodd-Frank reporting requirement, known as the Cardin-Lugar Transparency Amendment is expected to help remove corruption from the oil and gas mineral extraction industry.

International Oil Company Bribes and other FCPA violations as well as , International Oil Company False Reports and other SEC violations are forms of fraud that can result in whistleblower bounty actions, shareholder lawsuits, and several other types of litigation.  Petroleum employees including petroleum accountants, petroleum executives, and other oil company employees with original information of significant oil company fraud, international oil lease bribes to government officials, and other illegal conduct a large oil company may be able to collect a large reward through several whistleblower laws.

The key to obtaining a large whistleblower award is to make sure that as the international oil company whistleblower you are the first to file with sufficient evidence of significant fraud.  For more information on confidentially having your case reviewed, please go to the following web page: International Oil Company Whistleblower Reward Lawsuits

Sunday, February 3, 2013

Violations of the Foreign Corrupt Practices Act (FCPA) By Sub-Suppliers and Sub-Contractors Can Be The Basis of Bounty Actions By FCPA Sub-Contractor Lawyer and FCPA Sub-Supplier Lawyer

Violations of the Foreign Corrupt Practices Act (FCPA) Including Direct and Indirect Acts By Sub-Suppliers and Sub-Contractors Can Be The Basis of Bounty Actions By FCPA Sub-Contractor Lawyer and FCPA Sub-Supplier Lawyer

Globalization of supply chains has created a shift in where many component product parts are produced.  This shift includes the production of electronic components that are used in aircraft, military weapons systems, computers, medical equipment, and other products.  In many situations, large corporations and government contractors will use sub-contractors and sub-suppliers to produce these component parts.  These large corporations and government contractors can become the basis of a Bounty Action or Whistleblower Reward Lawsuit, when these sub-contractors and sub-suppliers 1) violate the FCPA, 2) produce faulty component parts, or 3) do business with prohibited parties.  

If you are aware of Foreign Corrupt Practice Act (FCPA) violations, sub-standard components, or other supply chain fraud, please feel free to contact FCPA Sub-Contractor Bounty Action Lawyer via e-mail message  or use our submission form.  Please also feel free to go to the following web pages for more information on International FCPA Bounty Actions and Whistleblower Reward Lawsuits

Faulty Electronic Components Can Be The Basis of FCPA Bounty Actions and Whistleblower Reward Lawsuits

Many electronic components were traditionally manufactured in the United States and Europe, but are now being manufactured in China, Mexico, India, and South America.  When these electronic components are fake or substandard parts, the general government contractor can sometimes be held to have made false certifications regarding the quality of these electronic components.  These false certifications can be the basis of a Qui Tam False Claims Act Whistleblower Reward Lawsuit.  

These lawsuits encourage whistleblowers including international whistleblowers along the electronic component supply chain to blow the whistle on fake military electronic components, low quality electronic components, and other counterfeit electronic parts.

For more information on this issue, please feel free to go to the following web pages: Defense Contractor False Certification Whistleblower Reward Lawsuits, and Military Contractor Fake Part Procurement Fraud Whistleblower Lawsuits.


 FCPA Violations Can Also Be The Basis of Bounty Actions

FCPA violations in the supply chain by sub-contractors and sub-suppliers can also be the basis of Bounty Actions that offer large rewards for persons with original and specialized knowledge of the violations.  These Bounty Actions can disgorge large contracts and be the basis of substantial recoveries for the whistleblower.  Further, recent whistleblower protections now allow whistleblowers to anonymously file bounty actions through a FCPA Bounty Action Lawyer.   

For more information on this issue please feel free to go to the following web pages: FCPA Violations in Pharmaceutical Industry, FCPA Violations in the Oil Industry, FCPA Violations in the Financial Services Industry, FCPA Violations in the Electronics Industry, and



Boeing and the Conduct of Due Diligence on Sub-Suppliers « FCPA Compliance and Ethics Blog
"The Foreign Corrupt Practices Act (FCPA) act has language which makes illegal a direct or indirect act which might be used to obtain or retain business from prohibited parties. This has caused companies to begin to look at their suppliers as one area which might give them FCPA exposure."

Monday, January 21, 2013

International Drug Company Fraud Bounty Action: Rewards Are Being Offered To Professionals That Expose International Drug Company Fraud by International Drug Company Fraud Lawyer

International Drug Company Fraud Bounty Action: Rewards Are Being Offered To Professionals That Expose Illegal Kickbacks, Illegal Bribes, Slush Funds, and Fraud Committed By International Drug Companies by International Drug Company Fraud Lawyer Jason S. Coomer

Worldwide government purchasing is estimated to be over $10 Trillion each year.  Of this amount a growing percentage of government contracts are for public health care, medical equipment, and drug contracts.  Because of the vast amounts of money governments are spending on drug contracts, medical equipment contracts, and other procurement contracts, several large corporations have targeted these contracts and are using illegal bribes, kickbacks, fraud, and other illegal actions to secure these contracts.  

As such, several governments have created reward laws called bounty actions that provide large financial incentives to persons with original knowledge of these crimes to confidentially and properly expose these crimes.  By working through an international bounty action lawyer, these people include many professionals can protect their identity and career, while exposing fraud and illegal conduct.

Confidentially Exposing International Drug Company Fraud and Illegal Conduct

If you are aware of a drug contract, medical equipment contract, or other government procurement contract that is the product of fraud, an illegal bribery scheme, illegal kickback scheme, and other illicit payment scheme, it is important that you properly report the government corruption and work with an international bounty action lawyer to determine the best way to expose the corruption.

To help determine if a large government corruption scheme may be a Foreign Corrupt Practices Act Whistleblower Reward Lawsuit, please feel free to send an e-mail message to International Drug Company Fraud Bounty Action Lawyer Jason Coomer

For more information on these issues, please feel free to go to the following web pages:

Procurement Fraud International Bounty Action Lawyer

GlaxoSmithKline Agrees to Pay $3 Billion in Fraud Settlement - NYTimes.com 

"In the largest settlement involving a pharmaceutical company, the British drugmaker GlaxoSmithKline agreed to plead guilty to criminal charges and pay $3 billion in fines for promoting its best-selling antidepressants for unapproved uses and failing to report safety data about a top diabetes drug, federal prosecutors announced Monday. The agreement also includes civil penalties for improper marketing of a half-dozen other drugs." 

Sunday, January 20, 2013

International Money Laundering Targeted: The United States Department of Justice and Securities Exchange Commission Are Offering Large Financial Rewards For Persons That Properly Expose International Bank Fraud and Money Laundering by International Money Laundering Lawyer Jason S. Coomer

International Money Laundering Targeted:  The United States Department of Justice and Securities Exchange Commission Are Offering Large Financial Rewards For Persons That Properly Expose International Bank Fraud and Money Laundering by International Money Laundering Lawyer Jason S. Coomer

The United States Department of Justice and Securities Exchange Commission are targeting banks, financial institutes and other large corporations that are illegally laundering money.  Large international corporations that are registered with the SEC and/or are doing business in the United States may be subject to substantial fines and penalties for money laundering, bank fraud, illegal kickbacks, fraudlent accounting practices, and other illegal activities.

Further, recent Bounty Actions have been enacted to provide large financial incentives to persons with original knowledge of these illegal activities to be the first to properly confidentially report these crimes.  For more information on these Bounty Action Laws and how to confidentially report money laundering, bank fraud, illegal kickbacks, fraudlent accounting practices, or other illegal activities,  please feel free to contact International Money Laundering Bounty Action Lawyer, Jason S. Coomer.

Please also feel free to go to the following web pages:

International Hedge Fund Fraud Bounty Action Lawyer

International Financial Services and Bank Fraud Bounty Action Lawyer  

For more information on International Crack Downs on Money Laundering, please also read the following article:

HSBC to pay $1.92 billion in money-laundering settlement - Dec. 10, 2012

Global banking giant HSBC will pay $1.92 billion in a record settlement with U.S. regulators to resolve money-laundering allegations.

The Department of Justice and U.S. Treasury said Tuesday that HSBC allowed the most notorious international drug cartels to launder billions of dollars across borders. In addition, the government said HSBC violated U.S. sanctions for years by illegally conducting transactions on behalf of customers in Iran, Libya, Cuba, Sudan and Burma.

Sunday, November 18, 2012

Russian Government Corruption Exposed: International Russian Whistleblowers Can Recover Large Financial Rewards for Exposing Corruption and International Bribery Schemes By International Whistleblower Reward Lawyer Jason Coomer

Exposing Russian Government Corruption and International Bribery Schemes: International Russian Whistleblowers Can Recover Large Financial Rewards for Properly Exposing Corruption and International Bribery Schemes Involving Multinational Corporations by International Whistleblower Lawyer Jason Coomer

Several Russian corruption stories are in the news as global efforts continue to expose government corruption in Russia.  Included in these efforts are new whistleblower reward laws that offer large financial rewards to whistleblowers that properly expose international bribery schemes and Russian government official illegal kickback schemes from large multinational corporations.  

Below are some recent news stories regarding corruption in Russia and information on international efforts to expose government corruption in Russia as well as reward people that are able to expose the corruption.

Trio Charged With Embezzling $110M in State Funds | News | The Moscow Times

Three high ranking official in Moscow have been charged with fraud, money laundering, and abetting the large scale theft of government funds.  These government officials fraudulently obtain the liability rights from several municipal entities.
fraudulently acquire liability rights from several municipal entities in the Moscow region totaling over 3.5 billion rubles [$110 million]

Read more: http://www.themoscowtimes.com/news/article/trio-charged-with-embezzling-110m-in-state-funds/471381.html#ixzz2CbMqTO7j
The Moscow Times

$470M in APEC Funds Were Misused, Audit Chamber Says | News | The Moscow Times

Billions of rubles have been misappropriated from Russian infrastructure projects ahead of the Asia Pacific Economic Conference.  Several key officials are the targets of the investigations as to significant amounts of stolen government funds.  These corruption scandals are expected to result in key arrests and resignations.  

With Anti-Corruption Drive, Kremlin Adopts Navalny Tactic | News | The Moscow Times

Several Russian Elites have been implicated in corruption scandals.  It is yet to be seen how severely these elites will be punished, however, exposing these elites is the first step and it appears that public pressure is building to force these elites out of power and seek back what they have stolen.

International Efforts to Help Expose & Prosecute Bribes and illegal kickbacks to Russian Government Officials & other Government Corruption by Foreign Corrupt Practices Act Attorney Jason Coomer
Russian whistleblowers, public officials,  business professionals, employees of multinational corporations, and others that have evidence of government corruption are eligible for large whistleblower financial rewards.  Russian government corruption that can be the basis for these awards include illegal payments for business; bribes for construction contracts; illegal incentives for oil, gas and mineral leases; illegal kickbacks for regulatory approval; and other violations of Foreign Corrupt Practices Act (FCPA).  Russian whistleblowers and multinational corporation whistleblowers are needed to step up to report illegal corrupt practices and can receive large financial rewards for being the first to properly expose significant Russian government corruption.  

If you are aware of a significant Foreign Corrupt Practice Act (FCPA) violation, please feel free to contact Russian Government Whistleblower  Lawyer,  Jason Coomer via e-mail message  or use our submission form to have an international law attorney review a potential Foreign Corruption Practices Act Securities and Exchange Commission (SEC) Action. 

Wednesday, October 31, 2012

Drug Bribes in The Pharmerging Countries: U.S. Foreign Bribery Penalties for Drugmakers May Need To Be Increased By Pharmerging Bribe Lawyer Jason S. Coomer

Pharmaceutical World Sales Increase to Over $880 Billion Per Year Including Large Sales Increases in the "Pharmerging Countries" by Pharmerging Bribe Lawyer Jason Coomer

Every year over $4.1 trillion (US dollars) is spent worldwide on health services including approximately $850 billion (US dollars) that is spent in the pharmaceutical market on drugs and medications.  In 2011, it is estimated that global pharmaceutical sales are expected to grow by 5% to 7% to around $880 billion.  This growth in sales is led by the 17 so-called "pharmerging countries," which include China, Brazil, Russia, India, Venezuela, Poland and the Ukraine.  These "pharmerging countries", are forecast to see their pharmaceutical spending grow at a 15% to 17% rate in 2011, to between $170 billion and $180 billion overall.

Eight pharmerging countries are amongst the top 20 world pharmaceutical markets, and China is one of the “top three” or will be in the near future.  A few high-profile pharmaceutical companies have been successful in gaining a foothold in these pharmering countries.  These footholds include Abbott’s acquisition of Piramal Healthcare in India — a deal that could potentially make the US giant the top player in this country.  Bayer's and Novartis' investments in China including Novartis'  commitment to invest $1 billion USD in R&D in China and its $125 million USD investment to buy 85 percent stake in a privately held vaccine company.  Pfizer has made inroads into the Russian health care system with a discount-card system in Russia  Sanofi Aventis has purchased Medley, Brazil’s third-largest pharmaceutical company.  GSK and Lilly have also announced anticipated doubling their revenue in emerging markets by 2015.

It is estimated that approximately 10 to 25% of public health care procurement spending including drug contracts, medicines, pharmaceuticals, medical equipment, and medical devices is lost to corrupt and fraudulent acts including adulterated drugs.  As such, there is an international movement to reward pharmaceutical professionals and health care professionals that expose fraudulent and corrupt practices that cost hundreds of billions of dollars and cost lives.  This international movement includes SEC Foreign Corrupt Practices Act Whistleblower Reward Lawsuits and traditional Qui Tam False Claims Act Whistleblower Reward Lawsuits.  


Analysis: U.S. foreign bribery penalties for drugmakers may lack bite | Reuters


"Federal authorities have cast a wide net to weed out suspected gift-giving and kickbacks to foreign doctors and government officials to gain a foothold in burgeoning new markets in Asia, Eastern Europe and Latin America."

"At least eight of the world's top 10 drugmakers, including Bristol-Myers Squibb Co, Pfizer Inc and Johnson &, have disclosed U.S. probes under the 1977 Foreign Corrupt Practices Act (FCPA).
Pfizer agreed to pay $60 million this year to settle FCPA charges and J&J reached a $70 million settlement last year. Pfizer is on track to record $10 billion in sales from emerging markets this year, while J&J said Brazil, Russia, India and China accounted for just under 10 percent of the $65 billion in sales it reported last year."

"With so much at stake outside of established markets in the United States and Europe, some experts say fines like these are hardly a deterrent."

"The $60 million fine for Pfizer to a lay person sounds like quite a bit of money, but in perspective it took less than two days of Lipitor sales during its peak. It's really just chump change for them," said Michael Leibfried, a senior analyst with market research consulting firm GlobalData. The cholesterol pill at its height was a $13 billion a year cash cow for Pfizer."


For more information on this topic, please feel free to contact Pharmerging Bribe Lawyer, Jason S. Coomer.

Thursday, October 11, 2012

Department of Justice Cracks Down On International Export of High Tech Microelectronics:International Trade Law News

U. S. Bureau of Industry and Security - DOJ Press Release - October 3, 2012

RUSSIAN AGENT AND 10 OTHER MEMBERS OF PROCUREMENT NETWORK
FOR RUSSIAN MILITARY AND INTELLIGENCE,
OPERATING IN THE U.S. AND RUSSIA, INDICTED


Defendants Also Include Texas- and Russia-Based Corporations
165 Persons and Companies ‘Designated’ by Commerce Department


BROOKLYN, NY – An indictment was unsealed today in United States District Court for the Eastern District of New York charging 11 members of a Russian military procurement network operating in the United States and Russia, as well as a Texas-based export company and a Russia-based procurement firm, with illegally exporting high-tech microelectronics from the United States to Russian military and intelligence agencies.1 Alexander Fishenko, an owner and executive of the American and Russian companies, is also charged with operating as an unregistered agent of the Russian government inside the United States by illegally procuring the high-tech microelectronics on behalf of the Russian government. The microelectronics allegedly exported to Russia are subject to strict government controls due to their potential use in a wide range of military systems, including radar and surveillance systems, weapons guidance systems, and detonation triggers.

The charges were announced by Loretta E. Lynch, United States Attorney for the Eastern District of New York; Lisa Monaco, Assistant Attorney General, National Security Division, Department of Justice; Stephen L. Morris, Special Agent in Charge, Federal Bureau of Investigation, Houston Field Office; Under Secretary of Commerce Eric L. Hirschhorn, Department of Commerce; and Timothy W. Reeves, Special Agent in Charge, Naval Criminal Investigative Service, Central Field Office. The arrested defendants will be arraigned later today before United States Magistrate Judge George C. Hanks, Jr., at the U.S. Courthouse in Houston, Texas, where the government will seek their removal to the Eastern District of New York.

In addition to the unsealing of the charges, search warrants were executed today at seven residences and business locations associated with the defendants, and seizure warrants were executed on five bank accounts held by Fishenko and defendant Arc Electronics, Inc., the Texas-based export company. In conjunction with the unsealing of these charges, the Department of Commerce has added 165 foreign persons and companies who received, transshipped, or otherwise facilitated the export of controlled commodities by the defendants to its “Entity List.” This designation imposes a license requirement before any commodities can be exported from the United States to these persons or companies, and establishes a presumption that no such license will be granted.


The Scheme

As alleged in the indictment, between approximately October 2008 and the present, Fishenko and the other defendants engaged in a surreptitious and systematic conspiracy to obtain advanced, technologically cutting-edge microelectronics from manufacturers and suppliers located within the United States and to export those high-tech goods to Russia, while carefully evading the government licensing system set up to control such exports. The microelectronics shipped to Russia included analog-to-digital converters, static random access memory chips, microcontrollers, and microprocessors. These commodities have applications, and are frequently used, in a wide range of military systems, including radar and surveillance systems, missile guidance systems and detonation triggers. Russia does not produce many of these sophisticated goods domestically.

According to the indictment and a detention motion filed by the government today, defendant Alexander Fishenko was born in what was, at the time, the Soviet Republic of Kazakhstan, and graduated from the Leningrad Electro-Technical Institute in St. Petersburg, Russia. He immigrated to the United States in 1994, and became a naturalized citizen of the United States in 2003. In 1998, he founded defendant Arc Electronics, Inc. (“Arc”) in Houston. Between 2002 and the present, Arc has shipped approximately $50,000,000 worth of microelectronics and other technologies to Russia. Fishenko and his wife are the sole owners of Arc, and Fishenko serves as the company’s President and Chief Executive Officer. Fishenko is also a part owner and executive of defendant Apex System, L.L.C. (“Apex”) a Moscow, Russia-based procurement firm. Apex, working through subsidiaries, served as a certified supplier of military equipment for the Russian government. Between 1996 and the present, Fishenko has regularly traveled back and forth between the United States and Russia. Defendant Alexander Posobilov entered the United States from Russia in 2001, and became a naturalized citizen in 2008. He joined Arc in 2004, and serves as its director of procurement. Posobilov was arrested at George Bush Intercontinental Airport in Houston on his way to Singapore and Moscow.

The defendants allegedly exported many of these high-tech goods, frequently through intermediary procurement firms, to Russian end users, including Russian military and intelligence agencies. To induce manufacturers and suppliers to sell them these high-tech goods, and to evade applicable export controls, the defendants often provided false end user information in connection with the purchase of the goods, concealed the fact that they were exporters, and falsely classified the goods they exported on export records submitted to the Department of Commerce. For example, in order to obtain microelectronics containing controlled, sensitive technologies, Arc claimed to American suppliers that, rather than exporting goods to Russia, it merely manufactured benign products such as traffic lights. Arc also falsely claimed to be a traffic light manufacturer on its website. In fact, Arc manufactured no goods and operated exclusively as an exporter.

According to the court documents, the defendants went to great lengths to conceal their procurement activities for the Russian military. For example, on one occasion, defendants Posobilov and Yuri Savin, the Director of Marketing at another Russian procurement firm, discussed how best to conceal the fact that certain goods Savin had purchased from Arc were intended for the Russian military. Savin asked Posobilov, “What can we do if a client is military all over?” Posobilov replied, “We can’t be the ones making things up. You should be the ones.” Similarly, on another occasion defendant Fishenko directed a Russian procurement company that, when the company provided false end user information, to “make it up pretty, correctly, and make sure it looks good.” On yet another occasion, Posobilov instructed a Russian procurement company to “make sure that” the end use certificate indicated “fishing boats, and not fishing/anti-submarine ones . . . Then we’ll be able to start working.”
Despite this subterfuge, according to the documents, the investigation revealed that the defendants were supplying Russian government agencies with sophisticated microelectronics. For example, the investigation uncovered a Russian Ministry of Defense document designating an Apex subsidiary as a company “certified” to procure and deliver military equipment and electronics. The FBI also recovered a letter sent by a specialized electronics laboratory of Russia’s Federal Security Service (“FSB”), Russia’s primary domestic intelligence agency, to an Apex affiliate regarding certain microchips obtained for the FSB by Arc. The letter stated that the microchips were faulty, and demanded that the defendants supply replacement parts.

In addition, in anticipation of an inquiry by the Department of Commerce regarding the export of certain controlled microelectronics, defendants Fishenko, Posobilov, and Arc salesperson Viktoria Klebanova allegedly directed Apex executives Sergey Klinov and Dmitriy Shegurov, as well as other Apex employees, to alter Apex’s website and forge documents regarding certain transactions to hide Apex’s connections to the Russian military. In connection with the cover-up, Apex removed images of Russian military aircraft and missiles and other links to the Russian Ministry of Defense from its website.

The Arc Defendants
In addition to Fishenko, Posobilov, and Klebanova, the indictment charges Arc salespersons Lyudmila Bagdikian, Anastasia Diatlova, Sevinj Taghiyeva, and Svetalina Zagon, as well as Arc shipping manager Shavkat Abdullaev, with one count of conspiring to violate and twenty-one counts of violating the International Emergency Economic Powers Act (“IEEPA”) and the Arms Export Control Act (“AECA”), and with conspiring to commit wire fraud. According to the indictment, these defendants obtained controlled microelectronics by lying and submitting false information regarding the true nature, users, and intended uses of the high-tech goods, then exporting the goods, without the required licenses, to procurement firms in Russia. The defendants’ principal port of export for these goods was John F. Kennedy International Airport in the Eastern District of New York.

The Foreign Defendants
According to the indictment, in addition to owning and controlling Arc, Fishenko is also a controlling principal of the Russian procurement firm Apex, the defendant Sergey Klinov is the chief executive officer of Apex, and the defendant Dmitriy Shegurov is an employee of Apex. Apex and its affiliates supplied microelectronics to Russian government agencies, including Russian military and intelligence agencies. The defendant Yuri Savin was the Director of Marketing at Atrilor, Ltd., another Russian procurement firm. Klinov, Shegurov and Savin conspired with Fishenko and the Arc defendants to obtain controlled U.S.-origin microelectronics and to export those technologically sensitive goods to Russia without the required export licenses by falsifying information to hide the true nature, users and intended uses of the goods. In addition, Fishenko, Posobilov, Klebanova, Klinov and Shegurov were charged with obstruction of justice, and Fishenko and Arc were charged with conspiring to commit money laundering.

The individual defendants face maximum terms of incarceration of five years for the conspiracy charge, twenty years for each of the substantive IEEPA and AECA charges, and twenty years for the obstruction of justice charge. In addition, Fishenko faces a maximum term of incarceration of twenty years for conspiring to commit money laundering, and ten years for acting as an unregistered agent of the Russian government. The corporate defendants face fines of up to $500,000 for the conspiracy count and $1,000,000 for each of the substantive IEEPA and AECA counts.

“As alleged in the indictment, the defendants spun an elaborate web of lies to evade the laws that protect our national security. The defendants tried to take advantage of America’s free markets to steal American technologies for the Russian government. But U.S. law enforcement detected, disrupted, and dismantled the defendants’ network,” stated United States Attorney Loretta E. Lynch. “We will not rest in our efforts to protect the technological advantage produced by American ingenuity. And, we will expose and hold responsible all who break our counter-proliferation laws, particularly those, like Fishenko, who serve foreign governments.” Ms. Lynch thanked the United States Attorney’s Office for the Southern District of Texas for its assistance in this matter.

“Today’s case underscores the importance of safeguarding America’s sensitive technology and our commitment to disrupt and prosecute networks that attempt to illegally export these goods,” said Lisa Monaco, Assistant Attorney General for National Security. “I applaud the many agents, analysts, and prosecutors who worked on this extensive investigation.”

“In this day and time, the ability of foreign countries to illegally acquire sensitive and sophisticated U.S. technology poses a significant threat to both the economic and national security of our nation,” said Houston FBI Special Agent in Charge Stephen L. Morris. “While some countries may leverage our technology for financial gain, many countries hostile to the United States seek to improve their defense capabilities and to modernize their weapons systems at the expense of U.S. taxpayers. The FBI will continue to work aggressively with our partners in the U.S. Intelligence Community to protect this technology and hold accountable those companies that willfully choose to violate our U.S. export laws.”

“Today’s action is a perfect example of two of the core benefits of the Administration’s export control reform effort – higher enforcement walls around controlled items and extensive coordination and cooperation among the enforcement agencies. I applaud our special agents who worked with the Justice Department in the interagency effort that led to today’s actions,” said Under Secretary of Commerce Eric L. Hirschhorn.

“The receipt of U.S.-made, cutting-edge microelectronics has advanced Russia’s military technological capabilities. NCIS and the Department of the Navy have worked closely with the FBI, the Department of Justice, and the Department of Commerce in this investigation due to the potential for significant enhancement of Russian naval weapons systems that would result from the illegal acquisition of these export-controlled technologies,” said Special Agent in Charge Timothy W. Reeves, NCIS Central Field Office.

As a result of this case, there may be victims and witnesses who need to contact the agencies involved in the investigation. If your business has been approached by one of the defendants, or by someone trying to obtain export-protected, sensitive technology who appeared not to be legitimate, please report that information to businessoutreach@leo.gov. The information will remain confidential and will be handled by the appropriate authorities.

The government’s case is being prosecuted by Assistant United States Attorneys Daniel Silver, Hilary Jager, and Claire Kedeshian, as well as Trial Attorney David Recker of the Counterespionage Section of the Department of Justice.
The Defendants:
Arc Electronics, Inc.
Principal Place of Business: Houston, Texas
Apex System, L.L.C.
Principal Place of Business: Moscow, Russia
Alexander Fishenko
Age: 46
Shavkat Abdullaev
Age: 34
Lyudmila Bagdikian
Age: 58
Anastasia Diatlova
Age: 38
Viktoria Klebanova
Age: 37
Sergey Klinov:
Age: 44
Alexander Posobilov
Age: 58
Yuri Savin:
Age: 36
Dmitriy Shegurov
Age: Unknown
Sevinj Taghiyeva
Age: 32
Svetalina Zagon
Age: 31


International Trade Law News

As a result of an investigation involving an alleged Russian military procurement network, the U.S. Department of Justice announced today that it had unsealed an indictment against two companies and 11 individuals located in the U.S. and Russia and executed a number of search warrants at various residences, businesses and banks in the U.S.

In a coordinated action, the Commerce Department's Bureau of Industry and Security (BIS) also issued a final rule (PDF) amending the Export Administration Regulations (EAR) to add 164 foreign persons and companies to the Entity List who allegedly received, transshipped or facilitated the exports of the items to Russia.